To ask the Scottish Executive whether the Health Technology Board for Scotland will report on the efficacy of the Al'heimer's drug Aricept, Rivastigmine and Galantamine and, if so, when or whether the recommendations of the National Institute for Clinical Excellence will be adopted in Scotland.